Invesaro

Stocks NOW Financial statements

Financial statements

ServiceNow, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ServiceNow, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,3911,9332,6093,4604,5195,8967,2458,97110,98413,278
Cost of revenue3995006237969871,3531,5731,9212,2872,983
Gross profit9921,4191,9862,6643,5324,5435,6727,0508,69710,295
Research and development2853785307491,0241,3971,7682,1242,5432,960
Selling and marketing6608951,2031,5341,8552,2922,8143,3013,8544,388
General and administrative1592112963394545977358639361,123
Operating expenses1,3741,4832,0292,6223,3334,2865,3176,2887,3338,471
Operating income-382-64.4-42.4421992573557621,3641,824
Interest expense33.353.452.733332827
Other non-operating income5.034.3856.158.3-16-28-38-56-45-14
Pre-tax income-410-113-39671502493991,0081,7382,261
Income tax3.833.44-12.3-560311974-723313513
Net income-414-117-26.76271192303251,7311,4251,748
EBITDA-29949.51072945357297881,3241,9282,562
EPS, basic-0.50-0.14-0.030.670.120.230.321.701.381.69
EPS, diluted-0.50-0.14-0.030.630.120.230.321.681.371.67
Shares, basic (weighted)8258588919359689931,0101,0211,0291,037
Shares, diluted (weighted)8258588919881,0151,0181,0201,0281,0421,047

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents4017265667761,6771,7281,4701,8972,3043,726
Short-term investments1,0539329151,4151,5762,8102,9803,4582,558
Receivables3234375758351,0091,3901,7252,0362,2402,627
Other current assets43.696132125192223280403668970
Total current assets1,3432,4222,3452,8274,5225,2206,6547,7779,18710,471
Property, plant and equipment1822453474686607661,0531,3581,7632,289
Lease right-of-use assets0402454591682715693806
Goodwill82.51291491572417778241,2311,2733,578
Intangible assets65.986.91011441532872322242091,121
Long-term investments3915821,0131,4681,6302,1173,2034,1113,771
Other non-current assets36.651.852.878100212359452291290
Total assets2,0343,5503,8796,0228,71510,79813,29917,38720,38326,038
Accounts payable38.132.130.753348927412668204
Accrued liabilities1722533304616688509751,3651,3691,813
Deferred revenue8621,2111,6522,1862,9633,8364,6605,7856,8198,314
Short-term debt09200
Total current liabilities1,0712,0392,0132,7533,7374,9496,0057,3658,35810,443
Long-term debt6951,640
Lease liabilities0383423556650707687800
Other non-current liabilities34.265.955.123.5365156118145220
Total liabilities1,6472,7722,7683,8945,8817,1038,2679,75910,77413,074
Total debt6951,6409201,491
Paid-in capital1,4051,7312,0942,4552,9743,6654,7966,1317,40110,747
Retained earnings-997-959-979-352-234-43382,0693,4945,242
Treasury stock0-535-1,219-3,045
Other comprehensive income-21.15.77-4.0425.39434-102-37-6819
Shareholders' equity5417791,1102,1272,8343,6955,0327,6289,60912,964
Total equity5417791,1102,1272,8343,6955,0327,6289,60912,964
Total liabilities and equity2,0343,5503,8796,0228,71510,79813,29917,38720,38326,038
Shares outstanding8398739039509821,0001,0172051,0321,047

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-414-117-26.76271192303251,7311,4251,748
Depreciation and amortization83.1114150252336472433562564738
Stock-based compensation3183945446628701,1311,4011,6041,7461,955
Deferred income tax-1.35-5.76-34.4-576-22-3415-85798251
Change in receivables-126-99.7-146-260-152-401-340-300-254-312
Change in payables-3.55-5.5-4.7621-3455172-142-5255
Cash from operations1596438111,2361,7862,1912,7233,3984,2675,444
Capital expenditures-106-151-224-265-419-392-550-694-852-868
Acquisitions-34.3-58.2-37.4-7-107-785-91-279-113-1,084
Purchases of investments-519-1,194-1,296-1,596-2,922-2,485-4,038-4,634-5,031-2,814
Sales and maturities of investments2724411,1951,159
Cash from investing-108-884-347-725-1,507-1,607-2,583-2,167-2,501-1,689
Debt issued001,48200
Share buybacks0-550000-538-696-1,840
Cash from financing-55.8539-607-302597-506-344-803-1,343-2,340
Exchange rate effect-5.9528-15.5025-25-531-177
Net change in cash-10.9326-15920990153-2574294061,422
Free cash flow53.54925879711,3671,7992,1732,7043,4154,576
Interest paid004124232322
Income taxes paid4.347.917.520393645127230283

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $135.62 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin74.8%Gross profit / revenue.
Operating margin11.4%Operating income / revenue.
EBITDA margin16.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin15.9%Pre-tax income / revenue.
Net margin11.3%Net income / revenue.
FCF margin31.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin36.0%Cash from operations / revenue.
Effective tax rate28.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)13.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.3%Net income / average total assets.
Return on invested capital (ROIC)7.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue22.1%Research and development expense / revenue.
Stock-based pay / revenue14.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.9%Capital expenditures / revenue.
D&A / revenue5.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y20.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y22.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y24.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y18.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y22.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y23.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y33.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y72.6%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y55.8%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y32.9%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y48.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y36.8%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y22.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y75.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y71.2%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y21.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y73.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y70.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y27.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y26.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y25.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y34.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y28.2%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y27.3%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y34.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y37.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y35.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y27.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y25.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y24.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.70xCurrent assets / current liabilities.
Quick ratio0.56x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.38x(Cash + short-term investments) / current liabilities.
Debt / equity0.43xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets17.2%Total debt / total assets.
Liabilities / assets60.5%Total liabilities / total assets.
Net debt$771.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.32xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital-$3.64BCurrent assets - current liabilities.
Goodwill and intangibles / assets43.0%(Goodwill + intangible assets) / total assets.
Tangible book value-$1.10BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.47xRevenue / average total assets.
Fixed asset turnover6.77xRevenue / average property, plant and equipment.
Receivables turnover6.69xRevenue / average receivables.
Days sales outstanding55 days365 x average receivables / revenue.
Days payables16 days365 x average accounts payable / cost of revenue.
FCF conversion274.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow13.7%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.61Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$14.24Revenue / diluted weighted shares.
FCF per share$4.43Free cash flow / diluted weighted shares.
Operating cash flow per share$5.13Cash from operations / diluted weighted shares.
Book value per share$12.11Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$1.07Tangible book value / shares outstanding.
Cash per share$4.51(Cash + short-term investments) / shares outstanding.
Buybacks / FCF74.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$140.23BShare price x shares outstanding.
Enterprise value$141.00BMarket cap + total debt - cash - short-term investments.
P/E84.0xMarket cap / net income. Only when net income is positive.
P/S9.52xMarket cap / revenue.
P/B11.2xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF30.6xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF26.4xMarket cap / cash from operations, when positive.
EV/Sales9.57xEnterprise value / revenue.
EV/EBIT83.9xEnterprise value / operating income, when both are positive.
EV/EBITDA57.8xEnterprise value / EBITDA, when both are positive.
EV/FCF30.8xEnterprise value / free cash flow, when both are positive.
FCF yield3.3%Free cash flow / market cap.
Earnings yield1.2%Net income / market cap (the inverse of P/E).
Shareholder yield2.4%(Dividends paid + share buybacks) / market cap.
PEG1.14xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was ServiceNow, Inc.'s revenue in fiscal 2025?

ServiceNow, Inc. reported revenue of $13.28B for fiscal 2025, 20.9% higher than the year before.

Was ServiceNow, Inc. profitable in fiscal 2025?

Yes. Net income was $1.75B, a net margin of 13.2%.

How much free cash flow did ServiceNow, Inc. generate in fiscal 2025?

Cash from operations of $5.44B minus capital expenditures of $868.0M left free cash flow of $4.58B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ServiceNow, Inc.